About Manly Haematology
Manly Haematology was founded by Dr Amanda Hugman, a clinical haematologist who lives locally on the Northern Beaches.
We are a private clinic where general practitioners and other medical specialists refer patients for diagnosis, a second opinion, or management of a haematological disorder.
Our focus is on ensuring that your journey from haematological diagnosis to treatment is streamlined and supported. You will be provided with a comprehensive explanation, and expert management in an ongoing relationship.
About Dr Amanda Hugman
Dr Hugman is a specialist haematologist based on the Northern Beaches. She divides her working week between St George Hospital and the Manly Haematology private practice.
Fellowships and Qualifications
Dr Amanda Hugman is a local specialist haematologist. She is a physician with fellowship training in both clinical and laboratory haematology. Dr Hugman completed medical training at the University of Sydney.
She undertook physician training at Royal Prince Alfred Hospital Sydney (RPAH) gaining dual fellowships with the RACP (Royal Australasian College of Physicians) and RCPA (Royal College of Pathologists of Australasia). Post-graduate fellowship was undertaken at Cambridge University’s Addenbrooke’s Hospital.
Undergraduate medical electives were undertaken at the University of Cape Town’s Groote Schuur Hospital and the rural township of Gove in the East Arnhem Region of Australia’s Northern Territory. During her post-graduate fellowship at Addenbrooke’s Hospital in Cambridge, she worked in the Department of Haematology with world-renowned experts, Dr Trevor Baglin (Thrombosis and Haemostasis) and Professor Tony Green (Myeloproliferative disorders).
Dr Hugman was awarded a Cancer Institute Clinical and Research Fellowship to complete research in molecular haematology at Royal Prince Alfred Hospital in 2007. This was undertaken at the Institute of Haematology RPAH under the supervision of Professor Harry Iland. She completed a Master of Philosophy in Medicine (University of Sydney) and published a thesis entitled ‘Analysis of Molecular Aberrations in Acute Myeloid Leukemias’ in 2011.
Awards
- 2007 NSW Cancer Institute Clinical and Research Fellowship in Molecular Haematology.
- 2008 HSANZ Haematology & Oncology Targeted Therapies Fellowship completing a research project on MEG3 and DLK1 expression in patients with AML.
Clinical Appointments
Dr Hugman is a Staff Specialist Haematologist in the Department of Haematology at St George Hospital in Kogarah. She divides her working week between St George Hospital and the Manly Haematology private practice. At St George Hospital she provides clinical care in the inpatient and outpatient setting. She manages patients with benign and malignant conditions including the provision of inpatient and outpatient chemotherapy and Autologous Bone Marrow Transplantation. She is a member of the St George Hospital Lymphoma Multidisciplinary Team.
She has a dual appointment with NSW Pathology and as such she provides supervision in the Haematology Laboratory of tests important in the diagnosis of haematological diseases. These include bone marrow biopsies, blood film interpretation, haemostasis, and platelet testing, haemoglobinopathy investigation and transfusion testing.
Dr Hugman provides lectures to St George Clinical School students and takes part in the undergraduate and post graduate Basic Physician training program. She has held responsibilities for safety and quality and clinical research at St George Hospital. Dr Hugman is passionate about clinical research and is an active participant in the St George Haematology Clinical Trials Unit. Dr Hugman is a sub-investigator on several malignant haematology trials. She is a Principal Investigator on haematology clinical trials.
Key Publications
JAMA, Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial, (2026)
Research and Practice in Thrombosis and Haemostasis, Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study, (2023)
Research and Practice in Thrombosis and Haemostasis, Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin, (2022)
Research and Practice in Thrombosis and Haemostasis, Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin, (2021)
European Respiratory Journal, Hokusai post-PE study: a follow-up study on long-term outcomes of pulmonary embolism in patients treated with edoxaban vs warfarin, (2020)
The Lancet. Haematology, Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial, (2015)
Blood, Triple Therapy For Immune Thrombocytopenia: A Novel Combination Of Conventional Strategies To Safely Sustain Platelet Counts In ITP, (2013)
Blood, All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4), (2012)
Thesis, University of Sydney, Analysis of Molecular Aberrations in Acute Myeloid Leukaemias, (2011)
International Journal of Laboratory Hematology, Development of a real-time semi-quantitative assay for JAK2 V617F mutation with case studies: 607, (2008)
Clinical and Laboratory Haematology, Hepcidin: an important new regulator of iron homeostasis, (2006)
What We Treat
We diagnose, monitor and manage a wide range of blood disorders, with a particular focus on benign (non-cancerous) conditions – including anaemia and other abnormal blood counts, clotting and bleeding disorders, thrombophilia and anticoagulation management, and paraprotein disorders such as MGUS. We also assess and manage selected malignant and pre-malignant conditions.